Skip to main content
. 2023 Mar 11;15(6):1369. doi: 10.3390/nu15061369

Table 4.

Reported adverse events for the entire study.

Placebo (n = 65) *
n (%)
MAG-EPA (n = 63) *
n (%)
Diarrhea 1 (1.5) 3 (4.8)
Skin rash 3 (4.6) 1 (1.6)
Nausea 1 (1.5) 3 (4.8)
Heartburn 0 1 (1.6)
Digestive problems 1 (1.5) 1 (1.6)
Change of stool frequency 1 (1.5) 1 (1.6)
Headaches 0 1 (1.6)
Total of patients with events 7 (10.8) 10 (15.9)
Withdrawal because of adverse events 1 (1.5) 5 (7.9)

Notes: * Adverse events are reported for all patients who had radical prostatectomy (n = 128). MAG-EPA: monoacylglyceride-conjugated eicosapentaenoic acid.